Health Canada Proposes a Streamlined Pathway for Certain Low-Risk Non-Prescription Drugs
Health Canada is proposing a streamlined authorization pathway for certain low-risk non-prescription drugs in Canada. Eligible List D products that fully comply with an applicable Health Canada monograph could be exempted from Division 8 “new drug” requirements and instead apply for a Drug Identification Number (DIN) under Division 1. The proposal may…